Urinary catheter alleviation navigator protocol (UCANP): Update to the hospital-wide implementation at a single tertiary health care center.

IF 3.8 3区医学 Q2 INFECTIOUS DISEASES

American journal of infection control Pub Date : 2024-06-12 DOI:10.1016/j.ajic.2024.06.001

Geehan Suleyman, Mallory E McCormick, Nicholas McLenon, Eman Chami, Edward Pollak, Ali A Dabaja

{"title":"Urinary catheter alleviation navigator protocol (UCANP): Update to the hospital-wide implementation at a single tertiary health care center.","authors":"Geehan Suleyman, Mallory E McCormick, Nicholas McLenon, Eman Chami, Edward Pollak, Ali A Dabaja","doi":"10.1016/j.ajic.2024.06.001","DOIUrl":null,"url":null,"abstract":"Background: Catheter-associated urinary tract infections are commonly reported health care-associated infections. It was demonstrated that the urinary catheter alleviation navigator protocol (UCANP) pilot resulted in a reduction of catheter utilization and catheter days.Methods: Quality improvement initiative that was implemented at a single urban, tertiary health care center, focusing on early discontinuation of indwelling urinary catheters (IUCs) and avoidance of reinsertion. The protocol was expanded hospital-wide from September 2020 to April 2022. We compared IUC utilization, IUC standardized utilization ratio (SUR), and catheter-associated urinary tract infection standardized infection ratio in the preintervention period (March 2020 to August 2020) to the postintervention period (May 2022 to October 2022).Results: Preimplementation, 2 patients with IUC removal were placed on UCANP. Postimplementation, 835 (45%) patients with IUC removal participated in the protocol. The number of patients requiring IUC reinsertion did not differ among the 2 groups. IUC utilization was significantly decreased from 0.28 to 0.24 with a 14% reduction (P = .025). SUR decreased by 11% from 0.778 to 0.693 (P = .007) and standardized infection ratio by 84% from 0.311 to 0.049 (P = .009).Conclusions: Our protocol significantly reduced IUC utilization and SUR after hospital-wide implementation. UCANP is a safe and effective strategy that can potentially decrease unnecessary IUCs in patients with transient urinary retention.","PeriodicalId":7621,"journal":{"name":"American journal of infection control","volume":null,"pages":null},"PeriodicalIF":3.8000,"publicationDate":"2024-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of infection control","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ajic.2024.06.001","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Catheter-associated urinary tract infections are commonly reported health care-associated infections. It was demonstrated that the urinary catheter alleviation navigator protocol (UCANP) pilot resulted in a reduction of catheter utilization and catheter days.

Methods: Quality improvement initiative that was implemented at a single urban, tertiary health care center, focusing on early discontinuation of indwelling urinary catheters (IUCs) and avoidance of reinsertion. The protocol was expanded hospital-wide from September 2020 to April 2022. We compared IUC utilization, IUC standardized utilization ratio (SUR), and catheter-associated urinary tract infection standardized infection ratio in the preintervention period (March 2020 to August 2020) to the postintervention period (May 2022 to October 2022).

Results: Preimplementation, 2 patients with IUC removal were placed on UCANP. Postimplementation, 835 (45%) patients with IUC removal participated in the protocol. The number of patients requiring IUC reinsertion did not differ among the 2 groups. IUC utilization was significantly decreased from 0.28 to 0.24 with a 14% reduction (P = .025). SUR decreased by 11% from 0.778 to 0.693 (P = .007) and standardized infection ratio by 84% from 0.311 to 0.049 (P = .009).

Conclusions: Our protocol significantly reduced IUC utilization and SUR after hospital-wide implementation. UCANP is a safe and effective strategy that can potentially decrease unnecessary IUCs in patients with transient urinary retention.

查看原文本刊更多论文

导尿管缓解导航协议（UCANP）：一家三级医疗保健中心在全院范围内实施的最新情况。

背景：导尿管相关性尿路感染（CAUTIs）是常见的医疗相关性感染。研究表明，导尿管缓解导航协议（UCANP）试点减少了导尿管使用率和导尿管使用天数：方法：在一个城市的三级医疗保健中心实施质量改进计划，重点是尽早停用留置导尿管（IUC）并避免再次插入。该计划于 2020 年 9 月至 2022 年 4 月在全院范围内推广。我们比较了干预前（2020 年 3 月至 2020 年 8 月）与干预后（2022 年 5 月至 2022 年 10 月）的 IUC 使用率、IUC 标准化使用率（SUR）和 CAUTI 标准化感染率（SIR）：结果：实施前，2 名 IUC 拔除患者接受了 UCANP 治疗。实施后，835 名（45%）拔除 IUC 的患者参与了该方案。需要重新植入 IUC 的患者人数在两组中没有差异。IUC使用率从0.28明显降低到0.24，降低了14%（P=0.025）。SUR从0.778降至0.693，降低了11%（p=0.007），SIR从0.311降至0.049，降低了84%（p=0.009）：我们的方案在全院范围内实施后，大大降低了IUC的使用率和SUR。UCANP是一种安全有效的策略，有可能减少一过性尿潴留患者不必要的IUC使用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American journal of infection control 医学-传染病学

CiteScore

7.40

自引率

4.10%

发文量

479

审稿时长

24 days

期刊介绍： AJIC covers key topics and issues in infection control and epidemiology. Infection control professionals, including physicians, nurses, and epidemiologists, rely on AJIC for peer-reviewed articles covering clinical topics as well as original research. As the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC)